|
I just finished four rounds of AC treatment and am about to start on taxol + herceptin as part of an adjuvant trial. I've been reading about taxol, and there seems to be a lot of literature questioning its effective. Susan Love writes that Europe does not approve it for the adjuvant setting. Even the company's own literature questions its effectiveness for ER positive breast cancer (which I am). Is there any research that says it's particularly helpful for her2? Am I alone in this concern? I worry about the potential neuropathy side effects.
Thanks,
Monica
|